Jpmorgan Chase & CO Enanta Pharmaceuticals Inc Transaction History

Jpmorgan Chase & CO

$1.1 Trillion
Q1 2024

A detailed history of Jpmorgan Chase & CO transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 138,047 shares of ENTA stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

138,047

Previous 150,821 8.47%

Holding current value

$1.79 Million

Previous $1.42 Million 69.84%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$10.08 - $17.46 $128,761 - $223,034	-12,774 Reduced 8.47%	138,047 $2.41 Million
Q4 2023 Feb 12, 2024	SELL	$8.18 - $10.78 $378,840 - $499,254	-46,313 Reduced 23.49%	150,821 $1.42 Million
Q3 2023 Nov 14, 2023	BUY	$11.09 - $22.13 $157,211 - $313,714	14,176 Added 7.75%	197,134 $2.2 Million
Q2 2023 Aug 11, 2023	BUY	$20.68 - $39.85 $326,309 - $628,793	15,779 Added 9.44%	182,958 $3.92 Million
Q1 2023 May 18, 2023	BUY	$38.82 - $54.59 $965,763 - $1.36 Million	24,878 Added 17.48%	167,179 $6.76 Million

Q1 2023 May 11, 2023	SELL	$38.82 - $54.59 $1.52 Million - $2.14 Million	-39,238 Reduced 21.61%	142,301 $5.75 Million
Q4 2022 Feb 13, 2023	BUY	$40.77 - $53.73 $363,505 - $479,056	8,916 Added 5.17%	181,539 $8.45 Million
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $242,946 - $358,559	-5,031 Reduced 2.83%	172,623 $8.95 Million
Q2 2022 Aug 11, 2022	BUY	$38.13 - $76.93 $5.27 Million - $10.6 Million	138,097 Added 349.11%	177,654 $8.4 Million
Q1 2022 May 11, 2022	BUY	$56.06 - $74.11 $129,050 - $170,601	2,302 Added 6.18%	39,557 $2.82 Million
Q4 2021 Feb 10, 2022	SELL	$60.19 - $97.37 $22,631 - $36,611	-376 Reduced 1.0%	37,255 $2.79 Million
Q3 2021 Nov 12, 2021	BUY	$41.02 - $58.65 $1.54 Million - $2.21 Million	37,631 New	37,631 $2.14 Million

Others Institutions Holding ENTA

# of Institutions

108

Shares Held

21.7M

Call Options Held

9.4K

Put Options Held

3.3K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $269M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Enanta Pharmaceuticals Inc Transaction History